Technology
Health
Biotechnology
Xencor
$32.849876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$32.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.14 (-0.42%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Xencor and other stocks, options, ETFs, and crypto commission-free!
About
Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. Read More The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Employees
156
Headquarters
Monrovia, California
Founded
1997
Market Cap
1.85B
Price-Earnings Ratio
50.48
Dividend Yield
0.00
Average Volume
247.47K
High Today
$33.20
Low Today
$32.62
Open Price
$33.20
Volume
45.03K
52 Week High
$48.38
52 Week Low
$27.75
Collections
Technology
Health
Biotechnology
Therapy
Cancer Prevention
2013 IPO
US
North America
News
Seeking AlphaMay 10
Xencor, Inc. CEO Bassil Dahiyat on Q1 2019 Results - Earnings Call Transcript
Xencor, Inc. (NASDAQ:XNCR) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Charles Liles - Associate Director & Head of Corporate Communications & Investor Relations Bassil Dahiyat - President & Chief Executive Officer Paul Foster - Senior Vice President & Chief Medical Officer John Kuch - Senior Vice President of Finance & Chief Financial Officer Conference Call Participants Ted Tenthoff - Piper Jaffray Jonathan Chang - SVP Leerink Eileen Maysek - Cantor Fitzgerald Sh...
Price Paid on Robinhood
2% Higher
Right Now
52 Week Low
$27.57
Average Price Paid
$32.31
52 Week High
$48.38
Earnings
-$0.62
$0.05
$0.71
$1.38
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 5, After Hours